In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “V ...

Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication There’s a pill on the market that few ...

Versions of the pill, which will be marketed as “Addyi”, have been submitted for approval in the past but never passed. FDA advisory meeting describe the drug's purpose as ”treatment of ...

Whether the “little pink pill” is a boon or a boondoggle depends on who you ask Flibanserin, soon to be marketed as Addyi ... safety studies, the drug finally got approval.

The drug will compete with Sprout Pharmaceuticals’ Addyi, a once-daily pill that was approved for HSDD in 2015 with a warning restricting alcohol use when on the medication. It will be available ...

The drug, Addyi, will be prescribed for patients with a condition known as acquired, generalised hypoactive sexual desire disorder (HSDD), or sudden and severe loss of libido. The non-hormonal ...